IN191496B - - Google Patents

Info

Publication number
IN191496B
IN191496B IN1036DE1999A IN191496B IN 191496 B IN191496 B IN 191496B IN 1036DE1999 A IN1036DE1999 A IN 1036DE1999A IN 191496 B IN191496 B IN 191496B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Yatendra Kumar
Rakesh Kumar Arora
Kaptan Singh
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN1036DE1999 priority Critical patent/IN191496B/en
Priority to BR0012865-1A priority patent/BR0012865A/pt
Priority to AU58391/00A priority patent/AU5839100A/en
Priority to CN00812246A priority patent/CN1371381A/zh
Priority to US10/048,354 priority patent/US6602999B1/en
Priority to JP2001513950A priority patent/JP2003506329A/ja
Priority to PCT/IB2000/001024 priority patent/WO2001009143A1/fr
Priority to EP00944159A priority patent/EP1204667A4/fr
Priority to ZA200200692A priority patent/ZA200200692B/en
Publication of IN191496B publication Critical patent/IN191496B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
IN1036DE1999 1999-07-30 1999-07-30 IN191496B (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IN1036DE1999 IN191496B (fr) 1999-07-30 1999-07-30
BR0012865-1A BR0012865A (pt) 1999-07-30 2000-07-24 Uma forma amorfa aperfeiçoada da proxetil cefpodoxima
AU58391/00A AU5839100A (en) 1999-07-30 2000-07-24 An improved amorphous form of cefpodoxime proxetil
CN00812246A CN1371381A (zh) 1999-07-30 2000-07-24 改进的无定形头孢泊肟酯
US10/048,354 US6602999B1 (en) 1999-07-30 2000-07-24 Amorphous form of cefpodoxime proxetil
JP2001513950A JP2003506329A (ja) 1999-07-30 2000-07-24 セフポドキシメプロキセチルの改良アモルファス形態
PCT/IB2000/001024 WO2001009143A1 (fr) 1999-07-30 2000-07-24 Forme amorphe amelioree de cefpodoxime proxetil
EP00944159A EP1204667A4 (fr) 1999-07-30 2000-07-24 Forme amorphe amelioree de cefpodoxime proxetil
ZA200200692A ZA200200692B (en) 1999-07-30 2002-01-25 An improved amorphous form of cefpodoxime proxetil.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1036DE1999 IN191496B (fr) 1999-07-30 1999-07-30

Publications (1)

Publication Number Publication Date
IN191496B true IN191496B (fr) 2003-12-06

Family

ID=11092065

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1036DE1999 IN191496B (fr) 1999-07-30 1999-07-30

Country Status (9)

Country Link
US (1) US6602999B1 (fr)
EP (1) EP1204667A4 (fr)
JP (1) JP2003506329A (fr)
CN (1) CN1371381A (fr)
AU (1) AU5839100A (fr)
BR (1) BR0012865A (fr)
IN (1) IN191496B (fr)
WO (1) WO2001009143A1 (fr)
ZA (1) ZA200200692B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
US7045618B2 (en) 2001-02-27 2006-05-16 Ranbaxy Laboratories Limited Cefpodixime proxetil
US20060106230A1 (en) * 2004-10-18 2006-05-18 Michael Pinchasov Processes for preparing amorphous atorvastatin hemi-calcium
EA200702518A1 (ru) * 2005-05-16 2008-04-28 Элан Фарма Интернэшнл Лимитед Композиции на основе наночастиц и с контролируемым высвобождением, включающие цефалоспорин
KR100840132B1 (ko) * 2007-04-17 2008-06-23 재단법인서울대학교산학협력재단 포화 액체 이산화탄소를 사용한 세포독심 프록세틸의 건조
EP2895464A4 (fr) * 2012-09-11 2016-06-15 Reddys Lab Ltd Dr Formes polymorphes d'enzalutamide et leur préparation
KR102225416B1 (ko) * 2012-09-11 2021-03-09 메디베이션 프로스테이트 테라퓨틱스 엘엘씨 엔잘루타마이드 제제
WO2017046756A1 (fr) * 2015-09-18 2017-03-23 Lupin Limited Esters de céfixime proxétil et axétil
JP2019520321A (ja) * 2016-05-09 2019-07-18 アナコール ファーマシューティカルズ，インコーポレイテッド フリー体のクリサボロールの結晶形ならびにそれらの調製方法および使用
US11447506B2 (en) 2016-05-09 2022-09-20 Anacor Pharmaceuticals, Inc. Crystal forms of crisaborole in free form and preparation method and use thereof
US10118932B2 (en) * 2016-06-16 2018-11-06 Xenon Pharmaceuticals Inc. Solid state forms of spiro-oxindole compounds
EP3510021A1 (fr) * 2016-09-06 2019-07-17 Indena S.p.A. Formes solides d'ingénol 3- (3,5-diéthylisoxazole-4-carboxylate) et leur procédé de préparation
US10336679B2 (en) * 2016-10-24 2019-07-02 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
US11369579B2 (en) 2016-10-24 2022-06-28 Syneurx International (Taiwan) Corp. Polymorphic forms of sodium benzoate and uses thereof
CN110248951B (zh) * 2017-02-01 2022-10-28 阿堤亚制药公司 用于治疗丙型肝炎病毒的核苷酸半硫酸盐
JP7365904B2 (ja) * 2017-03-30 2023-10-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング （ｓ）－［２－クロロ－４－フルオロ－５－（７－モルホリン－４－イルキナゾリン－４－イル）フェニル］－（６－メトキシ－ピリダジン－３－イル）メタノールの固体形態
IL305343A (en) * 2017-11-22 2023-10-01 Agios Pharmaceuticals Inc Crystal forms of N-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
MX2020010437A (es) * 2018-04-05 2021-01-29 Sumitomo Pharma Oncology Inc Inhibidores de axl cinasa y uso de los mismos.
KR20200140865A (ko) 2018-04-10 2020-12-16 아테아 파마슈티컬즈, 인크. 간경변증을 갖는 hcv 감염 환자의 치료
CN110251467A (zh) * 2019-06-26 2019-09-20 北京济美堂医药研究有限公司 一种无定形态头孢妥仑匹酯组合物的制备方法
CN110437259B (zh) * 2019-08-14 2021-12-07 中国药科大学 头孢泊肟酯柚皮素共无定形物及其制备方法
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
WO2022176017A1 (fr) * 2021-02-16 2022-08-25 大塚製薬株式会社 Matériau amorphe, et composition contenant celui-ci

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223153A (en) 1979-02-09 1980-09-16 Eli Lilly And Company Crystalline forms of N-2-(6-methoxy)benzothiazolyl N'-phenyl urea
IT1165253B (it) 1979-07-12 1987-04-22 Blasinachim Spa Procedimento di fabbricazione di acido chenodesossicolico cristallino puro
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
IL100091A (en) 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
ES2215161T3 (es) * 1991-09-07 2004-10-01 Aventis Pharma Deutschland Gmbh Diastereoisomero del ester 1-(isopropoxicarboniloxi)-etilico del acido 3-cefem-4-carboxilico y procedimiento para su preparacion.
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
AT413383B (de) * 1998-01-09 2006-02-15 Sandoz Ag Verfahren zur isolierung eines diastereoisomerengemisches von cefpodoxim proxetil
KR100342943B1 (ko) 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물

Also Published As

Publication number Publication date
US6602999B1 (en) 2003-08-05
BR0012865A (pt) 2002-07-09
JP2003506329A (ja) 2003-02-18
EP1204667A4 (fr) 2002-10-30
AU5839100A (en) 2001-02-19
WO2001009143A1 (fr) 2001-02-08
CN1371381A (zh) 2002-09-25
EP1204667A1 (fr) 2002-05-15
ZA200200692B (en) 2003-05-28

Similar Documents

Publication Publication Date Title
BE2018C020I2 (fr)
BE2015C057I2 (fr)
BE2016C007I2 (fr)
BE2015C018I2 (fr)
BE2014C017I2 (fr)
BE2013C051I2 (fr)
BE2013C020I2 (fr)
BE2013C015I2 (fr)
BE2013C001I2 (fr)
BE2012C036I2 (fr)
BE2011C004I2 (fr)
BE2010C011I2 (fr)
BRPI0017527B8 (fr)
JP2002502043A5 (fr)
JP2002507757A5 (fr)
BRPI0001672A2 (fr)
JP2000286458A5 (fr)
BRPI0001542A2 (fr)
JP2002528905A5 (fr)
BRPI0012675B8 (fr)
BRPI0017522A2 (fr)
IN187119B (fr)
JP2002525223A5 (fr)
IN187487B (fr)
BRMU7902607U2 (fr)